Literature DB >> 9794799

Purification of native p94, a muscle-specific calpain, and characterization of its autolysis.

K Kinbara1, S Ishiura, S Tomioka, H Sorimachi, S Y Jeong, S Amano, H Kawasaki, B Kolmerer, S Kimura, S Labeit, K Suzuki.   

Abstract

p94, a skeletal muscle-specific calpain, has attracted much attention because its gene is responsible for limb-girdle muscular dystrophy type 2A. p94, however, has not been characterized at the protein and enzyme levels, owing to its very rapid autolysis. In the present study, a purification procedure for p94 was first established by using a recombinant inactive p94 expressed in COS cells in which the active site cysteine residue was changed to serine [p94(C129S)]. The isolation of native p94 from rabbit skeletal muscle by the established method with conventional procedures was extremely difficult because p94 became highly unstable in a crude extract on the addition of NaCl for separation. Purification of native p94 was possible with an antibody-affinity column but only as an inactive enzyme; p94(C129S) was purified as a homodimer. Characterization of p94, especially autolysis, was performed with partly purified native p94 and p94(C129S). The autolysis of p94, which consisted at least partly of an intermolecular reaction, proceeded in three consecutive steps; 60 and 58 kDa fragments were produced as intermediates before a stable 55 kDa fragment appeared. Autolysis of p94 was regarded as a degradative step rather than for the activation of the enzyme. All the autolysis cleavage sites were located in the p94-specific insertion sequence 1 region, which explains why p94 is unstable compared with the other calpains. The autolysis sites in p94 clearly showed a different specificity relative to the autolytic and proteolytic cleavage sites of the ubiquitous mu- and m-calpains, in its preference for residues at the P3 to P1' sites, indicating a distinct substrate specificity and function for the muscle enzyme.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9794799      PMCID: PMC1219820          DOI: 10.1042/bj3350589

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  36 in total

1.  Molecular cloning of a novel mammalian calcium-dependent protease distinct from both m- and mu-types. Specific expression of the mRNA in skeletal muscle.

Authors:  H Sorimachi; S Imajoh-Ohmi; Y Emori; H Kawasaki; S Ohno; Y Minami; K Suzuki
Journal:  J Biol Chem       Date:  1989-11-25       Impact factor: 5.157

2.  Electroporation for the efficient transfection of mammalian cells with DNA.

Authors:  G Chu; H Hayakawa; P Berg
Journal:  Nucleic Acids Res       Date:  1987-02-11       Impact factor: 16.971

3.  A catalytic subunit of calpain possesses full proteolytic activity.

Authors:  T Yoshizawa; H Sorimachi; S Tomioka; S Ishiura; K Suzuki
Journal:  FEBS Lett       Date:  1995-01-16       Impact factor: 4.124

4.  Calpain dissociates into subunits in the presence of calcium ions.

Authors:  T Yoshizawa; H Sorimachi; S Tomioka; S Ishiura; K Suzuki
Journal:  Biochem Biophys Res Commun       Date:  1995-03-08       Impact factor: 3.575

Review 5.  Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage.

Authors:  K P Campbell
Journal:  Cell       Date:  1995-03-10       Impact factor: 41.582

Review 6.  Calpain: new perspectives in molecular diversity and physiological-pathological involvement.

Authors:  T C Saido; H Sorimachi; K Suzuki
Journal:  FASEB J       Date:  1994-08       Impact factor: 5.191

7.  Structural modifications associated with the change in Ca2+ sensitivity on activation of m-calpain.

Authors:  N Brown; C Crawford
Journal:  FEBS Lett       Date:  1993-05-03       Impact factor: 4.124

8.  Muscle-specific calpain, p94, is degraded by autolysis immediately after translation, resulting in disappearance from muscle.

Authors:  H Sorimachi; N Toyama-Sorimachi; T C Saido; H Kawasaki; H Sugita; M Miyasaka; K Arahata; S Ishiura; K Suzuki
Journal:  J Biol Chem       Date:  1993-05-15       Impact factor: 5.157

9.  Titin is an extraordinarily long, flexible, and slender myofibrillar protein.

Authors:  K Wang; R Ramirez-Mitchell; D Palter
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

10.  Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A.

Authors:  I Richard; O Broux; V Allamand; F Fougerousse; N Chiannilkulchai; N Bourg; L Brenguier; C Devaud; P Pasturaud; C Roudaut
Journal:  Cell       Date:  1995-04-07       Impact factor: 41.582

View more
  28 in total

1.  Molecular adaptations of neuromuscular disease-associated proteins in response to eccentric exercise in human skeletal muscle.

Authors:  L Féasson; D Stockholm; D Freyssenet; I Richard; S Duguez; J S Beckmann; C Denis
Journal:  J Physiol       Date:  2002-08-15       Impact factor: 5.182

2.  Homodimerization of calpain 3 penta-EF-hand domain.

Authors:  Ravikiran Ravulapalli; Beatriz Garcia Diaz; Robert L Campbell; Peter L Davies
Journal:  Biochem J       Date:  2005-06-01       Impact factor: 3.857

3.  Disruption of excitation-contraction coupling and titin by endogenous Ca2+-activated proteases in toad muscle fibres.

Authors:  Esther Verburg; Robyn M Murphy; D George Stephenson; Graham D Lamb
Journal:  J Physiol       Date:  2005-03-03       Impact factor: 5.182

4.  Effects of concentric and repeated eccentric exercise on muscle damage and calpain-calpastatin gene expression in human skeletal muscle.

Authors:  Kristian Vissing; Kristian Overgaard; Anders Nedergaard; Anne Fredsted; Peter Schjerling
Journal:  Eur J Appl Physiol       Date:  2008-03-14       Impact factor: 3.078

5.  PLEIAD/SIMC1/C5orf25, a novel autolysis regulator for a skeletal-muscle-specific calpain, CAPN3, scaffolds a CAPN3 substrate, CTBP1.

Authors:  Yasuko Ono; Shun-Ichiro Iemura; Stefanie M Novak; Naoko Doi; Fujiko Kitamura; Tohru Natsume; Carol C Gregorio; Hiroyuki Sorimachi
Journal:  J Mol Biol       Date:  2013-05-21       Impact factor: 5.469

6.  Glucose regulates protein catabolism in ras-transformed fibroblasts through a lysosomal-dependent proteolytic pathway.

Authors:  C Tournu; A Obled; M P Roux; M Ferrara; S Omura; D M Béchet
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

7.  Fibre type-specific expression of p94, a skeletal muscle-specific calpain.

Authors:  S W Jones; T Parr; P L Sensky; G P Scothern; R G Bardsley; P J Buttery
Journal:  J Muscle Res Cell Motil       Date:  1999-05       Impact factor: 2.698

8.  Endogenous calpain-3 activation is primarily governed by small increases in resting cytoplasmic [Ca2+] and is not dependent on stretch.

Authors:  Robyn M Murphy; Graham D Lamb
Journal:  J Biol Chem       Date:  2009-01-14       Impact factor: 5.157

9.  Characterization of a new p94-like calpain form in human lymphocytes.

Authors:  Roberta De Tullio; Roberto Stifanese; Franca Salamino; Sandro Pontremoli; Edon Melloni
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

Review 10.  Role of calpains in the injury-induced dysfunction and degeneration of the mammalian axon.

Authors:  Marek Ma
Journal:  Neurobiol Dis       Date:  2013-08-19       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.